Nanoparticle vaccine approach takes on a new target: Hepatitis C virus (IMAGE)
Caption
A native-like, stabilized version of the hepatitis C virus’ E1E2 glycoprotein complex (left). Many copies of these complexes were then mounted on self-assembling protein nanoparticles, a new type of vaccine candidate (right).
Credit
Scripps Research
Usage Restrictions
Can be used with related coverage and with credit
License
Original content